To compare methods of measuring angiogenic markers obtained through serum blood vs. trophoblast retrieval and isolation from the cervix (TRIC) and pregnancy outcomes in ovulatory and non-ovulatory cycles to verify its practical and clinical potential.
Who can participate?
- Age 18 to 40 years old
- Confirmed singleton intra-uterine pregnancy after ovulatory or non-ovulatory frozen embryo transfer
- Primiparous women
- Multiparous woman with previous uncomplicated livebirth pregnancy (no pre-eclampsia, hypertensive disorder of pregnancy, or gestational diabetes)
What is involved?
At 8-9 weeks of pregnancy, you will be asked to insert a menstrual cup into the vagina for 4-12 hours minimum. You will be provided with all the necessary supplies and instructions. You will have an appointment the next day for menstrual cup removal.
If interested in the study, we will offer an additional follow-up obstetrical ultrasound 1-2 weeks later at 8-9 weeks GA. The purpose of this ultrasound is to assess status of the pregnancy and at that time, to perform a serum blood test and collect TRIC samples. However, as this ultrasound is not part of standard care, it will be optional where the participant will still present at 8-9 weeks for serum blood and TRIC sampling only.
At 8, 12 and 20 weeks you will have blood work performed. These will be scheduled with routine prenatal tests or with routine prenatal appointments for your ease.
For more information: Please contact the research team at [email protected] or speak with your Mount Sinai Fertility Research Team at 416-586-8888 (ext. 3720 or 7151).
Please note that the security of email messages is not guaranteed. Messages may be forged, forwarded, kept indefinitely, or seen by others using the internet. Do not use email to discuss information you think is sensitive/confidential.